[CA-19-9 antigen analysis of bronchoalveolar lavage fluid contributing to therapeutic decision of pulmonary alveolar epithelial tumor].
Abe
K
K
Yamamoto
K
K
Takada
Y
Y
Ito
R
R
Kondo
K
K
Fujino
S
S
Fujioka
S
S
Hirasawa
T
T
Yokoyama
S
S
Kawano
N
N
Hiwada
K
K
D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000175:diagnosis* / Q000628:therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis*; D001992:Bronchoalveolar Lavage Fluid / Q000276:immunology*; D018395:CA-19-9 Antigen / Q000032:analysis*; D002945:Cisplatin / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D008937:Mitomycins / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D014747:Vinblastine / Q000008:administration & dosage
D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; D008937:Mitomycins; D014747:Vinblastine; D002945:Cisplatin